🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are proud to announce that #4oncommunity is now online!!! 4oncommunity.com [email protected] @NicolaFuscoMD Matteo Fassan OncoAlert Christian Rolfo International Society of Liquid Biopsy Pasquale Pisapia Alessandro Russo Valerio Gristina Gil Morgan, MD pvukovic Kamran Mirza MD PhD - کامران مرزا Dr. Iván R. González

CHIP is a common, age-related condition where mutated blood stem cells expand without causing blood disorders. CHIP raises the risk of hematological malignancies, chronic inflammatory diseases (like heart & lung disease), & lung cancer. This manuscript shows that CHIP somatic

This work is the result of a remarkable collaboration between **international experts**, and I'm incredibly proud of the insights we’ve brought forward. Grateful to the whole team for their dedication and effort.

#OpenAccess! | Current role of #cytopathology in the molecular & computational era: The perspective of young #pathologists. New avenues for collaboration, education, and remote consultation are opening. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #CytoPath Alessandro Caputo Vincenzo L'Imperio, MD Pasquale Pisapia

Congrats to my friend Chiara CATANIA for leading this multicenter international study on SCLC transformation in EGFRm NSCLCs with AR to EGFR TKI, shedding the light on a largely understudied issue. ESMO Open esmoopen.com/article/S2059-…

🩸È partito il nostro congresso "La biopsia liquida nel continuum of care del paziente oncologico"🌋 🎯Prima sessione incentrata sulla gestione clinica del paziente con malattia metastatica 💡 Umberto Malapelle Patologia Molecolare e Medicina di Precisione Francesco

💊#Datopotamab deruxtecan-dlnk accelerated approval by U.S. FDA ➡️Pts: #EGFR mutated #NSCLC ➡️Setting: locally advanced or metastatic ➡️Outcome: ORR 45% and median DOR 6.5 months ➡️Trials: TROPION-Lung 01 and 05 Christian Rolfo RolfoLab The James OncoAlert

🩸 È partita la seconda giornata di "La biopsia liquida nel continuum of care del paziente oncologico" 💡Molecular tumore board 🧑🏼‍🔬🧑🏼‍⚕️ Si parte con esperienze a confronto su: ✅ Colon ✅ Polmone 🧬Tutto armonizzato da Umberto Malapelle, our magic man ❤️

📣 New Method paper! Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing 👉 buff.ly/x2AGPRI #EpCAM #LungCancer #PleuralEffusion

Antonio Marra, oncologo medico della Divisione Nuovi Farmaci per Terapie Innovative IEO diretta da G Curigliano MD PhD , è stato selezionato tra i vincitori del Next Gen Clinician Scientist Grant, il prestigioso bando promosso da Fondazione AIRC per la ricerca sul cancro.

Early detection of renal cell carcinoma: a novel cell-free DNA fragmentomics-based liquid biopsy assay in ESMO Open. Mostly early stage RCC, promising non-invasive tool based on 3 cfDNA features integrated into a stacked ensemble ML model. esmoopen.com/article/S2059-…

Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study Adding chemo to osimertinib may benefit patients w/ EGFR + TP53 (L858R) more than those w/ Exon 19 del nature.com/articles/s4159…

🎉 Congratulazioni ad Antonio Marra per aver vinto il prestigioso grant Next Generation AIRC! Un traguardo straordinario che lo consacra tra gli oncologi del futuro. Si cura meglio solo se si fa ricerca Avanti così, Antonio! 💪🔬 Università degli Studi di Milano IEO #NextGenAIRC

Just in time for the new academic year - 50 years of progress in NSCLC in this review article JTO & JTO CRR led by Jarushka Naidoo & the IASLC communications committee. Proud to be part of this effort summarizing profound advances in this lethal disease. jto.org/article/S1556-…

📢 Big News from ISLB! The Journal of Liquid Biopsy is Now Indexed in Scopus 🎉 We’re proud to share that the Journal of Liquid Biopsy — the official journal of the International Society of Liquid Biopsy (ISLB) — has been accepted for indexing on the Scopus platform! This major

Excellent news!! Thanks Umberto Malapelle for your leadership and all the International Society of Liquid Biopsy executive board , team and members for the commitment! M JOSE SERRANO Lab (LB&Cancer Interception group) David Gandara ELO

"New kid on the block"! Accelerated approval for Sunvozertinib for EGFR Ex20ins-mutated NSCLC. An increasingly favorable therapeutic landscape ASCO IASLC International Society of Liquid Biopsy

❄️Winter of cancer immunotherapy is here. 𝐀𝐥𝐥-𝐜𝐨𝐦𝐞𝐫𝐬 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡 & 𝐍𝐞𝐭𝐰𝐨𝐫𝐤-𝐞𝐟𝐟𝐞𝐜𝐭 slowed progress-we’ve hit a plateau. Time to prioritize innovation over convention! Editorial out in JTO & JTO CRR bit.ly/4eEVcv4 Fabio Salomone Antonio Nuccio

Analysis of high risk features in #ALK & #ROS1 NSCLC JTO & JTO CRR. Liver metastases associated with shorter survival, but not brain metastases. Cumulative incidence of brain mets improving since 2017 in ALK NSCLC - likely reflecting more active TKIs. jtocrr.org/article/S2666-…

Wonderful to work with trainees Penn Path & Lab Medicine Penn Medicine CSO Clinicopathologic characteristics of papillary thyroid carcinoma, tall... sciencedirect.com/science/articl…